| Amgen Switzerland AG - Wezenla 90 mg/1 ml, Injektionslösung in einer Fertigspritze |
| 70188 | | 02 | | Wezenla 90 mg/1 ml | | Injektionslösung in einer Fertigspritze | | L04AC05 | | Ustekinumab | | 23.07.2025 | | |
|
| Composition |
| ustekinumabum 90 mg, saccharum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Ustekinumabum | 90 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Ustekinumabum | 90 mg |
| | | | Inactive agents |
|---|
| Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 1401.06 | 1540.15 | B | SL | No |
|
